Abstract: The invention relates to a process for preparing a fermented dairy product analogue having reduced sliminess and/or stickiness while using non-dairy ingredients comprising beta-glucans. The process comprises the following steps. An edible suspension comprising hydrophilic liquid and at least one non-dairy ingredient is provided. The non-dairy ingredient comprises beta-glucans and is selected from the group consisting of plant ingredient, fungal ingredient, or a combination thereof. After providing the edible suspension, ascorbic acid is added into said edible suspension. The resulting edible suspension comprising ascorbic acid is then homogenized, heat-treated, inoculated with a starter culture, and fermented to obtain a fermented dairy product analogue.

Abstract: The present invention relates to a fermented non-dairy food composition comprising: a) 5-10 wt. % oat, preferably 6-8 wt. % oat, b) 1.5-4 wt. % faba protein, c) 2-5 wt. % vegetable oil, d) water, and e) optionally added water binding fibers and wherein the food composition has a minimum PDCAAS of 0.80, preferably 0.90-0.95.

Abstract: Compositions and methods are described to enhance embryo implantation. Cytokines capable of binding to a receptor complex (the complex comprising a member of the hematopoietic cytokine receptor family) are utilized to treat female mammals, and in particular, females receiving in vitro fertilized embryos.

Abstract: The present invention provides an anticancer compound having the structure: ##STR1## wherein R is --H, --CH.sub.3, or --C.sub.2 H.sub.5 ; R1 and R2 are independently --H, --OH, --NH.sub.2, --OCH.sub.3, --C(CH.sub.3).sub.3, or a halogen atom; n is 2 to 6; X and X' are independently --N or --NO.sub.2 ; Y and Y' are independently --N, --CH, or --H; and the double-slash represents a double bond or no bond; such that when X or X' is --N, Y or Y' is --CH or --N, and the double-slash is a double bond, and when X or X' is --NO.sub.2, Y or Y' is --H, and the double-slash is no bond. The present invention also provides a pharmaceutical composition comprising the compound above and a pharmaceutically acceptable carrier.